Doctor profile · Federal record
Dr. Larinda Ogawa, PA-C
Medical Physician Assistant (CMS: Physician Assistant) · University Place, WA
- NPI 1669740924
- Accepts Medicare
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5225 Cirque Dr W Ste 200
University Place, WA 984673639
(253) 848-3000
fax (253) 845-8750 - Additional location
-
1703 S Meridian Ste 101
Puyallup, WA 983717590 - Mailing address
-
1703 S Meridian Ste 101
Puyallup, WA 983717590
Credentials & registration
- NPI registered
- December 2011 — 15 yrs on file
- Profile last updated
- April 6, 2018
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- Washington #60583901
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669740924. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,642
Distinct HCPCS
10
Medicare allowed
$128,285
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,171 | 186 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 352 | 289 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 285 | 230 | $46 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 175 | 142 | $107 | |
17110 |
Destruction of skin growth, 1-14 growths | 152 | 130 | $98 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 115 | 107 | $48 | |
11102 |
Biopsy of related skin growth, first growth | 97 | 92 | $79 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 60 | 60 | $95 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 42 | 35 | $146 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | 14 | $1 |
In context: peer comparison
Among 1 peers in University Place Medical Physician Assistant, average services per provider: 155. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$658
Transactions
34
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $220.73 | |
| Janssen Biotech, INC. | 3 | $108.13 | |
| Amgen INC. | 3 | $94.32 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $68.71 | |
| Ucb, INC. | 2 | $50.09 | |
| Novartis Pharmaceuticals Corporation | 2 | $44.73 | |
| Pfizer INC. | 2 | $38.11 | |
| Lilly USA, LLC | 1 | $16.88 | |
| Merz North America, INC. | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
343
Patients
221
Total drug cost
$105,106
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 70 | 59 | $883 |
| Hydrocortisone | Generic | 54 | 45 | $353 |
| Clobetasol Propionate | Generic | 53 | 35 | $3,880 |
| Ketoconazole | Generic | 48 | 29 | $808 |
| Betamethasone Dipropionate | Generic | 41 | 20 | $3,986 |
| Fluorouracil | Generic | 23 | 22 | $2,671 |
| Metronidazole | Generic | 16 | 11 | $855 |
| Clindamycin Phosphate | Generic | 15 | 0 | $827 |
| Humira(Cf) Pen (Adalimumab) | Brand | 12 | 0 | $90,588 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 11 | 0 | $256 |
Frequently asked questions
What is Dr. Larinda Ogawa's medical specialty?
Dr. Larinda Ogawa practices Medical Physician Assistant in University Place, WA.
Where does Dr. Larinda Ogawa practice?
Dr. Larinda Ogawa practices at 5225 Cirque Dr W Ste 200, University Place, WA 984673639. Office phone: 2538483000.
What is Dr. Larinda Ogawa's NPI?
Dr. Larinda Ogawa's National Provider Identifier (NPI) is 1669740924, issued by NPPES.
Does Dr. Larinda Ogawa accept Medicare assignment?
Yes. Dr. Larinda Ogawa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Larinda Ogawa commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.